Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Gilotrif... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=94677&sid=2
Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices of 70 scheduled formulations of Schedule-I under... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=94648&sid=2
AstraZeneca (BusinessWire India) 2016-04-14 Business Wire India AstraZeneca today reported new Phase I extended follow-up data on osimertinib... ...http://www.bizwireexpress.com/showstorybwi.php?storyid=9171
Head-to-head study demonstrating Giotrif ® (afatinib) significantly improved clinical outcomes compared to Iressa ® (gefitinib) in EGFR... ...http://businesswireindia.com/news/news-details/head-to-head-study-demonstrating-giotrifafatinib-significantly-improved-clinical-outcomes-compared-iressagefitinib-egfr-mutation-positive-advanced-nsclc-published-lancet-oncology/48197
Nagpur: The incidence of cancer is increasing by leaps and bounds. And though even today there is no complete cure for any cancer, the overall... ...http://m.timesofindia.com/city/nagpur/Targeted-therapy-yielding-good-results-in-cancer-treatment/articleshow/51802006.cms
Buy Gefitinib 250mg Tablets Online
Buy Gefitinib Iressa 250mg Tablets...
Gefitinib 250mg tablet is a...
Gefitinib, Erlonat, Veenat, Sorafenib.